Axon Enterprise, Inc $AXON Shares Purchased by Prakash Investment Advisors LLC

Prakash Investment Advisors LLC boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 128.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,250 shares of the biotechnology company’s stock after purchasing an additional 2,950 shares during the period. Axon Enterprise comprises approximately 2.5% of Prakash Investment Advisors LLC’s investment portfolio, making the stock its 13th biggest holding. Prakash Investment Advisors LLC’s holdings in Axon Enterprise were worth $3,768,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Westside Investment Management Inc. lifted its holdings in shares of Axon Enterprise by 4.8% in the 2nd quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock valued at $225,000 after buying an additional 13 shares during the period. CVA Family Office LLC increased its holdings in shares of Axon Enterprise by 26.9% during the 2nd quarter. CVA Family Office LLC now owns 66 shares of the biotechnology company’s stock valued at $55,000 after purchasing an additional 14 shares in the last quarter. Newbridge Financial Services Group Inc. boosted its holdings in Axon Enterprise by 2.8% during the second quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock worth $421,000 after buying an additional 14 shares in the last quarter. Vicus Capital grew its position in Axon Enterprise by 3.7% during the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 14 shares during the period. Finally, Evergreen Capital Management LLC raised its position in shares of Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock worth $342,000 after acquiring an additional 15 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on AXON shares. Piper Sandler reduced their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Royal Bank Of Canada assumed coverage on shares of Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target on the stock. Needham & Company LLC reduced their target price on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday. Finally, Barclays dropped their price target on Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $786.43.

Insiders Place Their Bets

In other Axon Enterprise news, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $550.63, for a total transaction of $55,063.00. Following the completion of the transaction, the director directly owned 1,316 shares of the company’s stock, valued at approximately $724,629.08. This trade represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Brittany Bagley sold 2,000 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares in the company, valued at $60,030,580. This represents a 1.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 48,040 shares of company stock worth $27,249,338 over the last quarter. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 2.6%

NASDAQ AXON opened at $441.12 on Friday. Axon Enterprise, Inc has a 1-year low of $396.41 and a 1-year high of $885.91. The company has a market capitalization of $34.81 billion, a price-to-earnings ratio of 139.60, a PEG ratio of 12.96 and a beta of 1.48. The stock’s 50 day moving average is $547.24 and its two-hundred day moving average is $640.09. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.